BrainStorm Cell Therapeutics
BCLI
#10185
Rank
NZ$11.71 M
Marketcap
$2.05
Share price
-6.50%
Change (1 day)
-87.32%
Change (1 year)

BrainStorm Cell Therapeutics (BCLI) - Cash on Hand

Cash on Hand as of September 2024 : NZ$0.3 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company has NZ$0.3 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

BrainStorm Cell Therapeutics - Cash on Hand chart (from 2002 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31NZ$4.69 M-85.47%
2021-12-31NZ$32.34 M-44.35%
2020-12-31NZ$58.12 M6779.2%
2019-12-31NZ$0.84 M-91.98%
2018-12-31NZ$10.53 M-3.57%
2017-12-31NZ$10.92 M-24.28%
2016-12-31NZ$14.42 M-38.13%
2015-12-31NZ$23.31 M113.85%
2014-12-31NZ$10.9 M155.72%
2013-12-31NZ$4.26 M-14.18%
2012-12-31NZ$4.96 M101.59%
2011-12-31NZ$2.46 M1943.97%
2010-12-31NZ$0.12 M8655.56%
2009-12-31NZ$0 M-60.05%
2008-12-31NZ$0 M-96.93%
2007-12-31NZ$0.11 M31.83%
2006-12-31NZ$0.08 M
2006-03-31NZ$0.47 M-36.03%
2005-03-31NZ$0.73 M10601.11%
2004-03-31NZ$0 M-61.75%
2003-03-31NZ$0.01 M-77.99%
2002-03-31NZ$0.08 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$20.66 B 6,885,614.29%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.92 B 640,382.14%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.21 B 736,203.57%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$4.24 B 1,413,590.48%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$72.24 M 23,969.64%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA